IOL Chemicals and Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

420.50

-20.55 (-4.66%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

420.50

-20.55 (-4.66%)
16:02 Dec 20

Quality

57/100
High Financial Strength

Valuation

61/100
Affordable Valuation

Technical

54/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	2184.02	2217.11	2132.79	2052.44
Operating Expenses +	1925.73	1991.44	1902.2	1865.89
Raw Material	1622.81	1565.29	1435.2	1382.13
Increase Decrease in Cost	-52.3	-18.2	-38.25	-11.65
Other Manufacturing Expense	0	0	0	0
Employee Cost	141.3	168.21	201.02	209.69
Miscellaneous Expenses	301.72	334.58	304.53	285.72
Operating Profit	258.29	225.67	230.59	186.55
Other Income	32.04	25.61	30.07	29.71
Depreciation	43.26	46.16	62.91	67.53
Interest	8.29	16.47	16.1	13.98
Profit before tax and exceptio..	238.78	188.65	181.65	134.75
Exceptional Items	-13.93	0	0	0
PBT	224.85	188.65	181.65	134.75
Provision for Taxation	57.18	49.51	47.22	34.93
Net Profit	167.67	139.14	134.43	99.82
NET Profit after MI	167.67	139.14	134.43	99.82
EPS	28.56	23.7	22.9	17.01
Operating Profit Margin (%)	11.83	10.18	10.81	9.09
Net Profit Margin (%)	7.68	6.28	6.3	4.86

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	48.20	48.20	48.20	48.20	48.20
FII	1.60	1.40	1.40	2.20	2.30
MF	0.00	0.10	0.10	0.10	0.00
Public	50.10	50.30	50.10	49.30	49.10
Others	0.00	0.00	0.00	0.00	0.00
Others	0.10	0.00	0.20	0.20	0.40